Investor Presentaiton

Consistent profitability and returns Gross Margin # EBITDA Margin 82% 83% 44% 45% 41% 75% 34% 74% 80% ill Net Margin (adjusted) 35% 32% 32% 32% 29% SUN PHARMA 18% FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 ROCE 28% 27% 24% 20% FY11 FY12 FY13 FY14 ROE 31% 26% 24% 18% 21% FY15 # Gross margin = (Net Sales- Material Cost)/ Net Sales * 100 ROCE & ROE exclude one-time exceptional charges Sun Pharmaceutical Industries Limited. All Rights Reserved. 20% Market Cap (USD Bn) 35 20 16 12 10 FY11 FY12 FY13 FY14 FY15 FY11 FY12 FY13 FY14 FY15 FY15 numbers include the impact of Ranbaxy merger 11

View entire presentation